Category Archives: Claiming Diagnostics

D. Mass Court Extends Myriad to Peptide Panels

Posted on September 6, 2016 by Warren Woessner

In a great leap backwards for patenting life sciences, Magistrate Judge Cabell invalidated claims in a number of patents licensed to Oxford Immunotec that are directed to e.g., “A kit for diagnosing infection in a human host by, or exposure … Continue reading →

Posted in Claiming Diagnostics, Obviousness, Patent Reform Legislation, Patentable Subject Matter | Leave a comment

Approaches to Claiming Diagnostic Methods using Biomarkers in the EPO

Posted on April 9, 2013 by Warren Woessner

Find linked below a guest post from Dr. Stefan Danner in regards to drafting diagnostic claims in Europe. Diagnostic Claims

Posted in Claiming Diagnostics, Patentable Subject Matter | Tagged Dr. Stefan Danner, EPO, Myriad, Patent Law, Prometheus, USPTO, Warren Woessner | Leave a comment